Dopamine agonists (DAs) are the most effective first-line drugs for treating PRL adenomas due to their functions of inhibiting PRL secretion and reducing tumor size (Shi et al., 2022), and DAs are also recommended for acromegaly with mild symptoms (Melmed and Longo, 2020). The gene discussed is PRL; the disease is neoplasm.